Article Menu
- Academic Editor
- Subscribe SciFeed
- Recommended Articles
- Related Info Links
-
More by Authors Links
- on DOAJ
- Tanaka, K.
- Tsuji, K.
- Hiraoka, A.
- Tada, T.
- Hirooka, M.
- Kariyama, K.
- Tani, J.
- Atsukawa, M.
- Takaguchi, K.
- Itobayashi, E.
- Fukunishi, S.
- Ishikawa, T.
- Tajiri, K.
- Ochi, H.
- Toyoda, H.
- Ogawa, C.
- Nishimura, T.
- Hatanaka, T.
- Kakizaki, S.
- Shimada, N.
- Kawata, K.
- Naganuma, A.
- Kosaka, H.
- Matono, T.
- Kuroda, H.
- Yata, Y.
- Ohama, H.
- Tada, F.
- Nouso, K.
- Morishita, A.
- Tsutsui, A.
- Nagano, T.
- Itokawa, N.
- Okubo, T.
- Arai, T.
- Yokohama, K.
- Nishikawa, H.
- Imai, M.
- Koizumi, Y.
- Nakamura, S.
- Iijima, H.
- Kaibori, M.
- Hiasa, Y.
- Kumada, T.
- on Google Scholar
- Tanaka, K.
- Tsuji, K.
- Hiraoka, A.
- Tada, T.
- Hirooka, M.
- Kariyama, K.
- Tani, J.
- Atsukawa, M.
- Takaguchi, K.
- Itobayashi, E.
- Fukunishi, S.
- Ishikawa, T.
- Tajiri, K.
- Ochi, H.
- Toyoda, H.
- Ogawa, C.
- Nishimura, T.
- Hatanaka, T.
- Kakizaki, S.
- Shimada, N.
- Kawata, K.
- Naganuma, A.
- Kosaka, H.
- Matono, T.
- Kuroda, H.
- Yata, Y.
- Ohama, H.
- Tada, F.
- Nouso, K.
- Morishita, A.
- Tsutsui, A.
- Nagano, T.
- Itokawa, N.
- Okubo, T.
- Arai, T.
- Yokohama, K.
- Nishikawa, H.
- Imai, M.
- Koizumi, Y.
- Nakamura, S.
- Iijima, H.
- Kaibori, M.
- Hiasa, Y.
- Kumada, T.
- on PubMed
- Tanaka, K.
- Tsuji, K.
- Hiraoka, A.
- Tada, T.
- Hirooka, M.
- Kariyama, K.
- Tani, J.
- Atsukawa, M.
- Takaguchi, K.
- Itobayashi, E.
- Fukunishi, S.
- Ishikawa, T.
- Tajiri, K.
- Ochi, H.
- Toyoda, H.
- Ogawa, C.
- Nishimura, T.
- Hatanaka, T.
- Kakizaki, S.
- Shimada, N.
- Kawata, K.
- Naganuma, A.
- Kosaka, H.
- Matono, T.
- Kuroda, H.
- Yata, Y.
- Ohama, H.
- Tada, F.
- Nouso, K.
- Morishita, A.
- Tsutsui, A.
- Nagano, T.
- Itokawa, N.
- Okubo, T.
- Arai, T.
- Yokohama, K.
- Nishikawa, H.
- Imai, M.
- Koizumi, Y.
- Nakamura, S.
- Iijima, H.
- Kaibori, M.
- Hiasa, Y.
- Kumada, T.
Need Help?
Article Versions Notes
| Action | Date | Notes | Link |
|---|---|---|---|
| article xml file uploaded | 31 August 2023 10:08 CEST | Original file | - |
| article xml uploaded. | 31 August 2023 10:08 CEST | Update | https://www.mdpi.com/2072-6694/15/17/4348/xml |
| article pdf uploaded. | 31 August 2023 10:08 CEST | Version of Record | https://www.mdpi.com/2072-6694/15/17/4348/pdf |
| article html file updated | 31 August 2023 10:09 CEST | Original file | https://www.mdpi.com/2072-6694/15/17/4348/html |
Cite
Tanaka, K.; Tsuji, K.; Hiraoka, A.; Tada, T.; Hirooka, M.; Kariyama, K.; Tani, J.; Atsukawa, M.; Takaguchi, K.; Itobayashi, E.; et al. Usefulness of Tumor Marker Score for Predicting the Prognosis of Hepatocellular Carcinoma Patients Treated with Atezolizumab Plus Bevacizumab: A Multicenter Retrospective Study. Cancers 2023, 15, 4348. https://doi.org/10.3390/cancers15174348
Tanaka K, Tsuji K, Hiraoka A, Tada T, Hirooka M, Kariyama K, Tani J, Atsukawa M, Takaguchi K, Itobayashi E, et al. Usefulness of Tumor Marker Score for Predicting the Prognosis of Hepatocellular Carcinoma Patients Treated with Atezolizumab Plus Bevacizumab: A Multicenter Retrospective Study. Cancers. 2023; 15(17):4348. https://doi.org/10.3390/cancers15174348
Chicago/Turabian StyleTanaka, Kazunari, Kunihiko Tsuji, Atsushi Hiraoka, Toshifumi Tada, Masashi Hirooka, Kazuya Kariyama, Joji Tani, Masanori Atsukawa, Koichi Takaguchi, Ei Itobayashi, and et al. 2023. "Usefulness of Tumor Marker Score for Predicting the Prognosis of Hepatocellular Carcinoma Patients Treated with Atezolizumab Plus Bevacizumab: A Multicenter Retrospective Study" Cancers 15, no. 17: 4348. https://doi.org/10.3390/cancers15174348
APA StyleTanaka, K., Tsuji, K., Hiraoka, A., Tada, T., Hirooka, M., Kariyama, K., Tani, J., Atsukawa, M., Takaguchi, K., Itobayashi, E., Fukunishi, S., Ishikawa, T., Tajiri, K., Ochi, H., Toyoda, H., Ogawa, C., Nishimura, T., Hatanaka, T., Kakizaki, S., ... Kumada, T., on behalf of the Real-life Practice Experts for HCC (RELPEC) Study Group and HCC 48 Group. (2023). Usefulness of Tumor Marker Score for Predicting the Prognosis of Hepatocellular Carcinoma Patients Treated with Atezolizumab Plus Bevacizumab: A Multicenter Retrospective Study. Cancers, 15(17), 4348. https://doi.org/10.3390/cancers15174348
